Migraine: navigating the hormonal minefield.

Afridi, Shazia K

Afridi, Shazia K.

Affiliation

Afridi SK; Neurology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK Shazia.Afridi@gstt.nhs.uk.

Pract Neurol ; 20(2): 115-121, 2020 Apr.

Article in En | MEDLINE | ID: mdl-31753858

ABSTRACT

ABSTRACT

Migraine affects 959 million people worldwide,1 with the highest prevalence being in women of childbearing age. The interplay between female hormones and migraine can be a challenging area to navigate since issues relating to pregnancy, contraception and the menopause are often out of the neurology comfort zone. This review aims to help the neurologist to manage women with migraine, from menarche to menopause.

Subject(s)

Gonadal Steroid Hormones/blood; Migraine Disorders/blood; Migraine Disorders/diagnosis; Anti-Inflammatory Agents, Non-Steroidal/pharmacology; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Contraceptives, Oral, Hormonal/pharmacology; Dietary Supplements; Female; Gonadal Steroid Hormones/antagonists & inhibitors; Humans; Lactation/blood; Lactation/drug effects; Menarche/blood; Menarche/drug effects; Menopause/blood; Menopause/drug effects; Migraine Disorders/drug therapy; Pregnancy; Tryptamines/pharmacology; Tryptamines/therapeutic use

Key words

contraception; hormone; menopause; menstrual; migraine; oestrogen; pregnancy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gonadal Steroid Hormones / Migraine Disorders Type of study: Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Pract Neurol Year: 2020 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google